<?xml version="1.0" encoding="UTF-8"?><Media xmlns:cdr="cips.nci.nih.gov/cdr" BlockedFromVOL="Yes">
 
 <MediaTitle>Childhood Cancer Genomics - AML Figure 1</MediaTitle>
 <PhysicalMedia>
  <ImageData>
   <ImageType>chart</ImageType>
   <ImageEncoding>JPEG</ImageEncoding>
   <Color>Color</Color>
   <Labeled>Yes</Labeled>
   <LabelName language="en">A</LabelName><LabelName language="en">Prevalence</LabelName><LabelName language="en">30%</LabelName><LabelName language="en">25%</LabelName><LabelName language="en">20%</LabelName><LabelName language="en">15%</LabelName><LabelName language="en">10%</LabelName><LabelName language="en">5%</LabelName><LabelName language="en">0%</LabelName><LabelName language="en">Mutation Type</LabelName><LabelName language="en">FLT3/ITD</LabelName><LabelName language="en">KIT CBF</LabelName><LabelName language="en">NPMC+</LabelName><LabelName language="en">WT1</LabelName><LabelName language="en">FLT3/ALM</LabelName><LabelName language="en">CEBPa</LabelName><LabelName language="en">RUNX1</LabelName><LabelName language="en">IDH2</LabelName><LabelName language="en">IDH1</LabelName><LabelName language="en">DNMT3A</LabelName><LabelName language="en">Adults</LabelName><LabelName language="en">27%</LabelName><LabelName language="en">25%</LabelName><LabelName language="en">20%</LabelName><LabelName language="en">10%</LabelName><LabelName language="en">7%</LabelName><LabelName language="en">5%</LabelName><LabelName language="en">11%</LabelName><LabelName language="en">9%</LabelName><LabelName language="en">8%</LabelName><LabelName language="en">22%</LabelName><LabelName language="en">Pediatric</LabelName><LabelName language="en">12%</LabelName><LabelName language="en">15%</LabelName><LabelName language="en">6%</LabelName><LabelName language="en">8%</LabelName><LabelName language="en">7%</LabelName><LabelName language="en">5%</LabelName><LabelName language="en">1%</LabelName><LabelName language="en">2%</LabelName><LabelName language="en">0%</LabelName><LabelName language="en">0%</LabelName><LabelName language="en">B</LabelName><LabelName language="en">Prevalence</LabelName><LabelName language="en">30%</LabelName><LabelName language="en">25%</LabelName><LabelName language="en">20%</LabelName><LabelName language="en">15%</LabelName><LabelName language="en">10%</LabelName><LabelName language="en">5%</LabelName><LabelName language="en">0%</LabelName><LabelName language="en">ITD prevalence</LabelName><LabelName language="en">0%</LabelName><LabelName language="en">1%</LabelName><LabelName language="en">7%</LabelName><LabelName language="en">18%</LabelName><LabelName language="en">25%</LabelName><LabelName language="en">23%</LabelName><LabelName language="en">NPMC+ prevalence</LabelName><LabelName language="en">1%</LabelName><LabelName language="en">0%</LabelName><LabelName language="en">5%</LabelName><LabelName language="en">5%</LabelName><LabelName language="en">10%</LabelName><LabelName language="en">13%</LabelName><LabelName language="en">CEBPA prevalence</LabelName><LabelName language="en">0%</LabelName><LabelName language="en">1%</LabelName><LabelName language="en">3.5%</LabelName><LabelName language="en">3%</LabelName><LabelName language="en">9%</LabelName><LabelName language="en">8%</LabelName><LabelName language="en">Age Group</LabelName><LabelName language="en">&lt;1 year</LabelName><LabelName language="en">1-&lt;2 years</LabelName><LabelName language="en">2-&lt;5 years</LabelName><LabelName language="en">5-&lt;10 years</LabelName><LabelName language="en">10-&lt;15 years</LabelName><LabelName language="en">&gt;15 years</LabelName><ImageDimensions>
    <HeightPixels>824</HeightPixels>
    <WidthPixels>522</WidthPixels>
   </ImageDimensions>
  </ImageData>
 </PhysicalMedia>
 <MediaSource>
  <OriginalSource>
   <Creator>Pediatric Clinics of North America</Creator>
   <SourcePublication>Tarlock K, Meshinchi S, Pediatric acute myeloid leukemia: biology and therapeutic implications of genomic variants. Pediatric Clinics of North America, Volume 62 (Issue 1),  Pages 75–93, Copyright 2015.</SourcePublication><DateCreated>2016-08-08</DateCreated>
   <SourceFilename>Tarlock Figure 4 for Ch Cancer Genomics 8-8-16.jpg</SourceFilename>
  <Comment audience="Internal" date="2016-08-08" user="kuhlmanna">Figure approved by PDQ Pediatric Treatment  Editorial Board and permissions received - 08/08/16</Comment><Comment audience="Internal" date="2015-09-01" user="kuhlmanna">Permissions needed; image added as draft for summary placeholder - need Board approval</Comment></OriginalSource>
 </MediaSource>
 <PermissionInformation>
    <PermissionRequested>Yes</PermissionRequested>
    
    <PermissionResponse>Permission Granted</PermissionResponse>
    <PermissionResponseDate>2016-08-04</PermissionResponseDate>
    
    <PublisherPermissionText>Reprinted from Pediatric Clinics of North America, Volume 62 (Issue 1), Katherine Tarlock, Soheil Meshinchi, Pediatric Acute Myeloid Leukemia: Biology and Therapeutic Implications of Genomic Variants, Pages 75–93, Copyright (2015), with permission from Elsevier.</PublisherPermissionText>
    <ApprovedUse>
     <Summary cdr:ref="CDR0000774921">Childhood Cancer Genomics</Summary>
     
    </ApprovedUse>
    <SpanishTranslationPermissionRequested>Yes</SpanishTranslationPermissionRequested>
    
    <CitationLink cdr:ref="CDR0000775152">Pediatric acute myeloid leukemia: biology and therapeutic implications of genomic variants.</CitationLink><Comment audience="Internal" date="2016-08-08" user="kuhlmanna">Figure approved by PDQ Pediatric Treatment  Editorial Board and permissions received - 08/08/16</Comment></PermissionInformation><MediaContent>
  <Categories>
   <Category>genetics</Category>
  </Categories>
  <Diagnoses>
   <Diagnosis cdr:ref="CDR0000038208">childhood acute myeloid leukemia/other myeloid malignancies</Diagnosis>
  </Diagnoses>
  
  <ContentDescriptions>
   <ContentDescription audience="Health_professionals" language="en">Charts showing (A) prevalence of AML-associated mutations in pediatric versus adult AML and (B) age-based prevalence of common AML-associated mutations.</ContentDescription>
  </ContentDescriptions>
  <Captions>
   <MediaCaption audience="Health_professionals" language="en">(A) Prevalence of AML-associated mutations in pediatric versus adult AML, demonstrating lower incidence of mutations in pediatric AML. Bordered panel shows 2 newly discovered mutations in adults that are absent in pediatric AML. (B) Age-based prevalence of common AML-associated mutations. Reprinted from Pediatric Clinics of North America, Volume 62, Katherine Tarlock, Soheil Meshinchi, Pediatric Acute Myeloid Leukemia: Biology and Therapeutic Implications of Genomic Variants, Pages 75–93, Copyright (2015), with permission from Elsevier.</MediaCaption>
  </Captions>
 </MediaContent>
 
 
<ProposedUse><Summary cdr:ref="CDR0000774921">Childhood Cancer Genomics;Treatment;Health professionals</Summary>
       <Summary cdr:ref="CDR0000062896">Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment</Summary>
       </ProposedUse><ProcessingStatuses><ProcessingStatus>
        <ProcessingStatusValue>Ready for Publishing</ProcessingStatusValue>
        <ProcessingStatusDate>2016-08-08</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>Copyright Permissions Received</ProcessingStatusValue>
        <ProcessingStatusDate>2016-08-05</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus><ProcessingStatus>
        <ProcessingStatusValue>HP illustration approved</ProcessingStatusValue>
        <ProcessingStatusDate>2016-07-22</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus>
       <ProcessingStatus>
        <ProcessingStatusValue>HP illustration pending</ProcessingStatusValue>
        <ProcessingStatusDate>2016-07-13</ProcessingStatusDate>
        <EnteredBy>kuhlmanna</EnteredBy>
        
       </ProcessingStatus></ProcessingStatuses><RelatedDocuments>
         <SupplementaryInfoLink cdr:ref="CDR0000782666">Tarlock_Figure_CopyrightPermissions_2016-08-05</SupplementaryInfoLink>
       </RelatedDocuments></Media>
